Living Cell Technologies today announced the approval by NZ Government to start Phase 1 clinical trials for the treatment of Parkinsons Disease, the second most prevalent neurodegenerative disease after Altzeimers Disease. The trials will commence 1 Qtr 2013.
The company now has 2 diseases targeted with the Type 1 Diabetes trials proceeding towards implementation in the near future. The Parkinsons trials will take 60 weeks and therefore the company will be closely watched by the medical fraternity.
parkinson's disease clinical trials approval
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 1AI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.81M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.7¢ | 0.6¢ | $41.21K | 6.825M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 3056700 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 913000 | 5 |
View Market Depth
| Last trade - 15.36pm 27/09/2024 (20 minute delay) ? |
| 1AI (ASX) Chart |